Efficient and persistent transduction of exocrine and endocrine pancreas by adeno-associated virus type 8
Efficient delivery of therapeutic proteins into the pancreas represents a major obstacle to gene therapy of pancreatic disorders. The current study compared the efficiency of recombinant lentivirus and adeno-associated virus (AAV) serotypes 1, 2, 5, 8 vectors delivered by intrapancreatic injection for gene transfer in vivo. Our results indicate that lentivirus and AAV 1, 2, 8 are capable of transducing pancreas with the order of efficiency AAV8 >>AAV1 > AAV2 >/= lentivirus, whereas AAV5 was ineffective. AAV8 resulted in an efficient, persistent (150 days) and dose-dependent transduction in exocrine acinar cells and endocrine islet cells. Pancreatic ducts and blood vessels were also transduced. Extrapancreatic transduction was restricted to liver. Leukocyte infiltration was not observed in pancreas and blood glucose levels were not altered. Thus, AAV8 represents a safe and effective vehicle for therapeutic gene transfer to pancreas in vivo.
Publication Source (Journal or Book title)
Journal of biomedical science
Cheng, H., Wolfe, S. H., Valencia, V., Qian, K., Shen, L., Phillips, M. I., Chang, L., & Zhang, Y. C. (2007). Efficient and persistent transduction of exocrine and endocrine pancreas by adeno-associated virus type 8. Journal of biomedical science, 14 (5), 585-94. https://doi.org/10.1007/s11373-007-9159-1